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Abstract 
 
Chemical comparisons of powder and hydrated forms of calcium silicate cements 
(CSCs) and calculation of alterations in tricalcium silicate (Ca3SiO5) calcium 
hydroxide (Ca(OH)2) are essential for understanding their hydration processes. This 
study aimed to evaluate and compare these changes in ProRoot MTA, Biodentine and 
CEM cement. Powder and hydrated forms of tooth coloured ProRoot MTA, 
Biodentine and CEM cement were subjected to X-ray diffraction (XRD) analysis with 
Rietveld refinement to semi-quantitatively identify and quantify the main phases 
involved in their hydration process. Data were reported descriptively. Reduction in 
Ca3SiO5 and formation of Ca (OH)2 were seen after the hydration of ProRoot MTA 
and Biodentine; how-ever, in the case of CEM cement, no reduction of Ca3SiO5 and 
no formation of Ca(OH)2 were detected. The highest percentages of amorphous 
phases were seen in Biodentine samples. Ettringite was detected in the hydrated forms 
of ProRoot MTA and CEM cement but not in Biodentine. 
 
 
Introduction 
 
Mineral trioxide aggregate (MTA) is a calcium silicate– based 
cement (CSCs) used in dentistry with various clini-cal 
applications, such as vital pulp treatment modalities, 
endodontic surgery, one step orthograde root end clo-sure, 
sealing of perforations, orifice plugs and regenera-tive 
endodontic (1). Many disadvantages have been reported for 
this CSC such as difficult handling properties (1,2) and tooth 
discoloration (3,4). Several other CSCs have been developed 
with the aim of overcoming these disadvantages. 
 
Biodentine (Septodont, Saint Maur des Fosses, France) 
 
is a fast setting CSC with high compressive strength (5) 
 
 
that is marketed as a dentin replacement material (6). The 
powder is composed of tricalcium silicate, zirconium oxide 
and calcium carbonate, whereas the liquid supplied for mixing 
includes calcium chloride as an accelerator and a hydrosoluble 
polymer as a water-reducing agent (7). 
 
Calcium-enriched mixture cement (CEM cement) 
(Bionique, Tehran, Iran) is a white CSC, with no discol-oration 
potential (3). It is composed of calcium oxide (CaO), sulphur 
trioxide (SO3), phosphorus pentoxide (P2O5) and silicon 
dioxide (SiO2). 
 
X-ray diffraction (XRD) can be used to analyse and 
characterise the crystal phases in both powder and hydrated 
forms of CSCs (8,9). This technique recognises 
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specific diffraction peaks that are particular to the various 
crystalline phases present in each material (10) such as 
calcium hydroxide crystalline structures (8,9). Rietveld 
refinement, in turn, is used for the quantitative analysis of 
these detected crystalline phases (11). 
 
The assessment, quantification and comparison of the 
crystalline phases in CSCs before and after hydration is 
important for improving our understanding of cement 
composition and changes occurring during the setting process 
(9). Therefore, the aim of this study was to quan-titatively 
evaluate the crystalline phases present in the powder and 
hydrated forms of tooth coloured ProRoot MTA, Biodentine 
and CEM cement using Rietveld-XRD analysis. 
 
 
Materials and methods 
 
This study has been approved by the Endodontology Research 
Group of Cardiff University, UK. 
 
Sample preparation 
 
Both powder and hydrated forms of three CSCs were 
investigated: tooth coloured ProRoot MTA (Dentsply 
Maillefer, Ballaigues, Switzerland); Biodentine (Septo-dont, 
Saint-Maur-des-Fosses, France); and CEM cement 
(BioniqueDent, Tehran, Iran). 
 
To investigate the hydrated form of cements, mixing was 
performed as follows: i) for tooth coloured ProRoot MTA and 
CEM cement, the mixing of the material was standardised by 
placing 1 g of the powder in a sterilised amalgam capsule (2). 
Then, 0.33 g of their respective liq-uids, distilled water for 
MTA and phosphate-buffered solution (PBS) for CEM cement 
were added to the cap-sules. ii) For Biodentine, five drops of 
the liquid provided were added to the powder, which is 
packaged in a plastic capsule. 
 
The encapsulated materials were then mixed mechani-cally 
for 30 s at 4500 rpm (2) using an amalgamator (Dentsply 
Caulk, York, PA, USA). Subsequently, mixed slurries were 
placed in three prefabricated cylindrical sili-cone moulds (Elite 
Double 22; Zhermack SpA, Rome, Italy) with dimensions of 6 
0.1 mm length and 4 0.1 mm internal diameter and subjected 
to a con-stant vertical compaction force of 3.22 MPa applied 
for 1 min (12). The moulds were then incubated at 37°C in 
fully saturated conditions for 7 days. 
 
 
Rietveld-XRD analysis 
 
Both the dry powders and the hydrated forms of the mate-rials 
(2 g each group) were subjected to Rietveld-XRD analysis for 
evaluation of their crystalline structures. 
 
 
The hydrated materials were crushed to fine powder before 
analysis. Phase compositions of specimens from each group 
were determined using an X-ray diffractome-ter (PANalytical 
X’Pert PRO, Almelo, Netherlands) and CuKa radiation (40 Kv 
and 40 mA). Scans were under-taken from 10° to 80° in the 2h 
range with 0.02° step. In order to identify crystalline 
compounds, all patterns were matched using the database of 
the International Centre for Diffraction Data (ICDD, 
Pennsylvania, PA, USA). The Rietveld refinement tool was 
used for the quantitative analysis of phases resulted in six 
diffractograms: three for the original powder and three for the 
hydrated form. 
 
Data analysis 
 
To semi-quantitatively analyse the main phases related to the 
CSC hydration process, Rietveld refinement with the 
PANalytical X’Pert PRO software was used to adjust XRD 
spectra (diffractogram) in each sample. For this numeri-cal 
simulation, the standard crystalline phases reported in the 
literature were used, according to the Inorganic Crys-tal 
Structure Database (ICSD), as follows: tricalcium sili-cate 
(Ca3SiO5) [64759], dicalcium silicate (Ca2SiO4) [166637], 
calcium hydroxide (CaOH2) [91882], trical-cium aluminate 
(Ca3Al2O6) [163579], the radiopacifiers bismuth oxide 
(Bi2O3) [15072], zirconium oxide (ZrO2) [82543], and barium 
sulphate (BaSO4) [167519]. Addi-tional phases detected in the 
samples were added to the spectra during the adjustments and 
are reported descrip-tively (%) with their respective ICSD 
codes. 
 
Results 
 
XRD patterns in the 10°–80° 2h range and Rietveld analy-sis 
results are shown in Figures 1–3. All samples consisted of 
tricalcium silicate and dicalcium silicate. 
 
Figure 1 reveals the following: 
 
(a) a diffractogram for tooth coloured ProRoot MTA, 
 
powder form (G1 powder): showing mainly tricalcium 
 
silicate (Ca3SiO5) and bismuth oxide (Bi2O3) peaks, as 
well as dicalcium silicate (Ca2SiO4). Rietveld analysis 
 
identified and quantified the following phases: 14.4% 
 
Bi2O3 [15072], 79.6% Ca3SiO5 [64759], 0.3% Ca2SiO4 
[166637], 3.9% CaAl2O6 [163579] and 1.8% CaSO4 
[15876]; and 
 (b) a diffractogram for tooth coloured ProRoot MTA, 
hydrated form (G1 hydrated): showing the same 
 
phases of the powder sample, that is, tricalcium sili- 
 
cate (Ca3SiO5), dicalcium silicate (Ca2SiO4), and bis-muth 
oxide (Bi2O3), plus calcium hydroxide (Ca [OH]2) peaks 
and a small peak for ettringite (E). Riet-veld analysis found 
15.8% Bi2O3 [15072], 44.9% Ca3SiO5 [64759], 6.6% 
Ca2SiO4 [166637], 17.9% Ca 
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Figure 1 Diffractogram and Rietveld analysis for tooth coloured ProRoot MTA, (a) powder and (b) hydrated form. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 Diffractogram and Rietveld analysis for Biodentine, (a) powder and (b) hydrated form. 
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Figure 3 Diffractogram and Rietveld analysis for CEM cement, (a) powder and (b) hydrated form. 
 
(OH)2 [91882] and 6.9% Ca6Al2(SO4)(OH)2.26H2O 
[155395]. Material hydration revealed new crystalline 
phases, and the rearrangement caused some type of disorder, 
represented by 7.9% of an amorphous phase. Monoclinic 
and triclinic forms of tricalcium silicate were not 
distinguishable in MTA samples. Figure 2 reveals the 
following: 
 (a) a diffractogram for Biodentine, powder form (G2 
 
powder): two different structures of tricalcium silicate 
 
(Ca3SiO5): triclinic [162744] and monoclinic [64759] were 
found. Rietveld analysis showed 56.6% Ca3SiO5 (triclinic 
structure), 23.8% Ca3SiO5 (monoclinic struc-ture), 4.7% 
ZrO2 and 14.9% CaCO3 [180348]; and 
 (b) a diffractogram for Biodentine hydrated form (G2 
 
hydrated): the same phases of the powder sample, that 
 
is, tricalcium silicate (Ca3SiO5), dicalcium silicate 
(Ca2SiO4), calcium carbonate (CaCO3), calcium hydroxide 
(Ca[OH]2) and zirconium oxide (ZrO2) 
 
peaks were found. Rietveld analysis showed 22.5% 
 
Ca3SiO5 [162744] (only the triclinic structure), 4.0% 
Ca(OH)2 [91882], 24.8% CaCO3 [180348], 4.7% ZrO2 
 
[82543] and 44.0% amorphous phase. 
 
Figure 3 reveals the following: 
 
(a) a diffractogram for CEM Cement powder form (G3 
 
powder): tricalcium silicate (Ca3SiO5), dicalcium sili-cate 
(Ca2SiO4), dicalcium silicate c–phase (c–Ca2SiO4) and 
barium sulphate (BaSO4) peaks. Quantification 
 
with Rietveld analysis found 19.0% BaSO4 [167519], 
53.1% Ca3SiO5 [162744] (triclinic structure), 5.3% c– 
Ca2SiO4 [417503] and 22.6% Ca2SiO4 [79552]; and 
 (b) a diffractogram for CEM Cement hydrated form 
 
(G3 hydrated): tricalcium silicate (Ca3SiO5), dicalcium 
silicate (Ca2SiO4), barium sulphate (BaSO4) and 
 
ettringite (E) peaks. Rietveld analysis showed 10.7% 
 
BaSO4 [167519], 57.7% Ca3SiO5 [64759] (monoclinic 
structure), 2.8% Ca2SiO4 [166637], 5.9% Ca6Al2(-
SO4)3OH12.H2O [155395] and 22.8% amorphous phase. 
 
 
Discussion 
 
Investigating the crystalline phases of the hydrated forms of 
CSCs and comparing it with their unhydrated powder and 
calculation of reduction in tricalcium sili-cate and formation of 
calcium hydroxide powder form was an attempt to better 
understand the hydration and setting of these cements (8,9,13). 
Differences in the for-mation of calcium hydroxide may result 
in various bio-logical properties (14,15). The wide range of 
applications of CSCs (16,17) and the current scarcity of 
evidence regarding the hydration process of Biodentine and 
CEM Cement highlight the clinical importance of crystalline 
phase analysis and comparison of these materials. 
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According to the results of this study, as expected Ca3SiO5 
was the predominant phase detected in all evalu-ated non-
hydrated CSCs. During the initial stages of cement hydration, 
this phase reacts with water producing calcium hydroxide 
(7,9). Triclinic and monoclinic poly-morphic phases of 
Ca3SiO5 were only distinguishable in Biodentine and CEM 
cement and not in ProRoot MTA. The triclinic form was 
predominant in Biodentine and this was consistent with the 
study by Grech and coworkers (18). The powder form of CEM 
cement only contained the triclinic form. After hydration, no 
triclinic form could be detected in CEM cement and only the 
monoclinic form was detected. After hydration of Biodentine, 
both forms of Ca3SiO5 reduced and no monoclinic form was 
found. The temperature used during the sintering process of 
cement production and presence of impurities determine the 
exist-ing polymorphic phases of Ca3SiO5 (19,20), therefore 
indi-cating differences in the manufacturing temperatures used 
in the cements evaluated (21). 
 
In the hydrated form of all three CSCs, an increase in the 
amorphous phase was seen. Greater amounts of amorphous 
phase tend to increase the hardness of mate-rials (13). The 
highest percentage of amorphous phase was seen in Biodentine 
(44%), with the percentage of this phase being 22.8% and 
7.9% for CEM cement and tooth coloured ProRoot MTA, 
respectively. This greater percentage in Biodentine may 
indicate an advanced hydration in relation to the other two 
materials. In this regard, it is important to point out that the 
liquid of Bio-dentine contains calcium chloride as a setting 
accelerator (18,22). Furthermore, this cement contains calcium 
car-bonate, which acts as a nucleation site for C-S-H, reduc-
ing the duration of the induction period and consequently 
causing the setting reaction to start a few minutes after mixing 
(10). 
 
In this study, calcium hydroxide crystalline structures were 
only detected in the hydrated forms of ProRoot MTA and 
Biodentine. These changes occur consequent to the hydration 
of calcium silicate, which begins soon after the powder and 
liquid are combined and produces cal-cium silicate hydrate gel 
(C-S-H) and calcium hydroxide. Interestingly, in the case of 
CEM cement, no crystalline calcium hydroxide was detected 
after the hydration of CEM cement. 
 
Soluble Ca(OH)2 is released from the cement surface of 
CSCs during hydration (23), improving the alkalinity of the 
surrounding environment (24) and resulting in antibacterial 
properties (25). The reaction of soluble Ca (OH)2 with 
phosphate present within body fluids and/or the phosphate 
present within the cement’s liquid can result in the formation 
of hydroxyapatite (26,27). There-fore, the bioactivity and 
biocompatibility of CSCs are enhanced by releasing Ca(OH)2 
(27). Furthermore, when 
 
soluble Ca(OH)2 reaches saturated concentrations, crys-talline 
Ca(OH)2 will be formed (14,28). Therefore, in the case of 
CEM cement, lack of crystalline Ca(OH)2 may contribute to 
either early hydroxyapatite formation or sub-saturated 
concentrations of soluble Ca(OH)2. Consid-ering that no 
reduction was seen in the peaks of trical-cium silicate in CEM 
cement, the latter is more likely to be the cause but more 
research is required regarding this matter. 
 
Ettringite was detected in the hydrated forms of Pro-Root 
MTA and CEM cement as aluminate is present in their 
composition. This crystalline complex contains cal-cium, 
aluminium, silicon and sulphur and is responsible for 
resistance and hardening in the early hydration stage 
 
(9). The absence of ettringite peaks in the hydrated form of 
Biodentine may be a consequence of the reduction (or 
absence) of the aluminate phase in its powder form (10). The 
reduction/absence of the aluminate phase is an added benefit 
with respect to the workability of the fresh cement paste (10). 
It is associated with biological improvements, for example, 
avoiding the undesirable effects of aluminium (e.g. risks of 
Parkinson’s and Alzhei-mer’s disease) (29) and avoiding the 
leaching of trace ele-ments into surrounding tissues (30). 
 
The alternative radiopacifiers detected in Biodentine (ZrO2) 
and in CEM cement (BaSO4) are an attempt to improve their 
chemical and mechanical properties. Bi2O3 has the potential to 
increase the setting time, decrease mechanical strength and 
increase the porosity of CSCs (13,22). It has been suggested 
that Bi2O3 present in Pro-Root MTA, unlike other 
radiopacifiers, is not inert during the cement hydration process 
(9,21). Rather, it has been reported to be present in the 
hydrated phase, forming a structure comprised of calcium 
silicate bismuth hydrate (C-S-H-Bi), which would affect 
Ca(OH)2 precipitation and, consequently, the bioactivity of the 
hydrated mate-rial (9,21). In addition, a reduced amount of C-
S-H will produce a poorer and slower hydration reaction, 
result-ing in a longer setting time and deterioration of 
mechani-cal properties (13), factors that would impact 
negatively on the clinical use of ProRoot MTA. On the 
contrary, the findings of this study revealed no reduction in the 
amount of Bi2O3 detected. This inconsistency may be due to 
different methodologies. For instance, in the study by 
Camilleri et al. (9,21), analysis was conducted 1 month after 
cement preparation. Further research is suggested to evaluate 
the amount of Bi2O3 at different time intervals after cement 
preparation. 
 
 
 
Conclusion 
 
The hydrated form of CEM cement had a different beha-viour 
in relation to tricalcium silicate and Ca(OH)2 peaks 
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when compared with the hydrated forms of Biodentine and 
ProRoot MTA. In CEM cement, no reduction in tri-calcium 
silicate occurred and formation of calcium hydroxide was not 
detected. Biodentine did not have ettringite in its hydrated 
form, in contrast to the other cements. The highest percentage 
of amorphous phase was seen in Biodentine. 
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